Proteins conferring immunity against pore-forming colicins are localized in the Escherichia coli inner membrane. Their protective effects mediated by direct interaction with the C-terminal domain of their cognate colicins. Cai, the immunity protein protecting E. coli against colicin A, contains four cysteine residues. We report cysteine cross-linking experiments showing that Cai forms homodimers. Cai contains four transmembrane segments (TMSs), and dimerization occurs via the third TMS. Furthermore, we observe the formation of intramolecular disulfide bonds that connect TMS2 with either TMS1 or TMS3. Coexpression of Cai with its target, the colicin A pore-forming domain (pfColA), in the inner membrane prevents the formation of intermolecular and intramolecular disulfide bonds, indicating that pfColA interacts with the dimer of Cai and modifies its conformation. Finally, we show that when Cai is locked by disulfide bonds, it is no longer able to protect cells against exogenous added colicin A.
Pore-forming colicins are plasmid-encoded bacteriocins, synthesized by Enterobacteriacae, that are lethal to other related strains. Like many toxins, colicins are organized into structural domains that perform different functions: the N-terminal and the central domains are involved in the transport through the Escherichia coli envelope and the C-terminal domain carries the toxic activity of the protein (1) .
The three-dimensional structures of the soluble form of the pore-forming domains of colicins A, E1, Ia, B and N share the same general architecture: a bundle of eight amphipathic α-helices surrounding two hydrophobic α-helices (H8+H9), completely buried within the protein (2-6). However, crystal structures do not reveal the structure of the channel in the membrane, which remains uncharacterized. The hydrophobic helical hairpin may be the primary attachment region for channel formation and channel opening and closing require insertion and extrusion of an amphipathic segment, which has not been precisely defined (7, 8) .
Each colicin plasmid also encodes a specific immunity protein that protects the producing cell against the cytotoxic activity of its colicin. Immunity proteins are integral inner membrane proteins. They are classified into two groups according to sequence similarities: the A-type (immunity proteins to colicins A, B, N and U) and the E1-type (immunity proteins to colicins E1, 5, K, 10, Ia and Ib) (9) (10) (11) . The colicin A immunity protein (Cai) has four transmembrane segments (TMSs), and its Nand C-termini are in the cytoplasm (Fig. 1) , whereas the immunity protein to colicin E1 (Cei) crosses the cytoplasmic membrane three times, with the N-terminus located in the cytoplasm and the C-terminus in the periplasm (10, 11) .
The immunity proteins to pore-forming colicins diffuse laterally in the membrane and interact with helices of the pore-forming domain of their cognate colicin just prior channel opening (12) (13) (14) (15) . Genetic studies of Atype colicins indicate that the main determinant recognized by the immunity protein is the hydrophobic helical hairpin (12, 16) . Similar studies with an E1-type colicin suggested that inactivation of the toxin is due to interaction between the voltage-gated regions of colicin and the TMSs of the immunity proteins (14, 15) . The first biochemical evidence of pore-forming colicin physically interacting with its immunity protein was reported by Espesset et al., (1996) who showed that a colicin A pore-forming domain, fused to a prokaryotic signal peptide (sp-pfColA), could be co-immunoprecipitated with its cognate epitope-tagged immunity protein (EpCai) (17) . Using the same coimmunoprecipitation procedure, Nardi et al. (2001) demonstrated that the smallest fragment of colicin A recognized by Cai was the hydrophobic helical hairpin (18) .
However, little is known about the tertiary structure of immunity proteins within the membrane. For example, there have been no investigations of whether immunity proteins are in monomeric or oligomeric states. Only limited and preliminary data are available concerning the arrangement of helices in the membrane and the residues in close contact between TMSs have not been identified. Here, we describe the use of site-directed cysteine cross-linking to gain insight into the interaction surfaces of Cai at the structural level. Copper (II) orthophenanthroline (Cu-OP), a commonly used cross-linking reagent, was employed to catalyze the formation of disulfide bonds between SH groups. EpCai has four cysteine residues, all located in its TMSs. We show that EpCai forms a covalent dimer in the membrane upon incubation with Cu-OP, and we identified the cysteine residue involved in EpCai dimerization. In addition to dimer formation, we also detected intramolecular disulfide bonds that connect TMS1 to TMS2 and TMS2 to TMS3. Interestingly, intra and intermolecular disulfide bonds formation was abolished when sp-pfColA was co-expressed. Moreover, if EpCai is oxidized with Cu-OP treatment, it is no longer able to protect cells against exogenously added colicin A. These various findings indicate that in vivo EpCai forms a dimer in the membrane and changes conformation upon interaction with the colicin A pore-forming domain.
EXPERIMENTAL PROCEDURES
Strain, plasmids, and growth conditions. E. coli C600 was used as the recipient strain for all cloning procedures. Plasmid pImTC encodes the wild type Cai under the control of its own promoter (19) . Plasmid pEpCaiCm encodes the epitope-tagged immunity protein (EpCai) (19) . pVL1 encodes the wild-type Cai with the 178 first amino acids of ColA fused to its N-terminus (20) . pCT1 encodes the poreforming domain of ColA fused to the PelB sequence signal (sp-pfColA) (21) . pCT3 encodes the B3 mutant form of sp-pfColA (sppfColA B3 ) (21) . pBAD/HisC contains the araBAD promoter from E. coli and was used to insert the gene encoding sp-pfColA or sppfColAB3. Routinely, cells were grown aerobically at 37°C or 30°C, in LB medium supplemented with ampicillin (100 µg/ml), kanamycin (50 µg/ml) or chloramphenicol (40 µg/ml).
Constructs. QuickChange mutagenesis PCR with complimentary pairs of oligonucleotides was used to introduce site-directed substitutions. Genes encoding sp-pfColA and sp-pfColAB3 were amplified by PCR using appropriate 5' and 3' primers. The 5' primers contained the DNA sequence (30 bp) of pBAD/HisC immediately upstream from the ATG start codon and the DNA sequence encoding the first eight amino-acids of the signal peptide of sp-pfColA or sp-pfColAB3. The 3' primers correspond to the DNA sequence encoding of the N-terminal eight amino-acids of sp-pfColA or sp-pfColAB3 and contained the DNA sequence (30 bp) of pBAD/HisC immediately upstream from the ATG. Once amplified, the DNA fragments encoding sp-pfColA or sp-pfColAB3 were used as megaprimers and inserted into pBAD/HisC by a second-stage PCR that amplified the whole plasmid.
Colicin assay. Colicin activity was assessed by the formation of halos on a lawn of the target strain, as described previously (22) . The data are reported as the highest dilution of colicin solution that still inhibits cell growth (table 1) . Strains sensitive or immune to ColA were spread on LB medium agar plates containing or not containing Cu-OP (200 µM).
In vivo disulfide bond formation and immunodetection. Aliquots of 8 X 10 8 exponentially growing cells (A 600 = 0.6) were pelleted and resuspended in 1 ml of 10 mM sodium phosphate buffer (NaPi, pH 6.8), and then treated with 1 mM EDTA (pH 8) and 5 mM N-ethylmaleimide (NEM, Sigma) to block reduced thiols groups. The cells were treated, as appropriate, with the indicated concentration of the oxidative catalyst Cu-OP (Sigma) prior to treatment with EDTA and NEM. The cells were subsequently pelleted and resuspended in Laemmli loading buffer in the presence or absence of β-mercaptoethanol (β-me). In vivo formaldehyde cross-linking was performed as described previously (23) . Proteins were separated by 15% SDS-PAGE, and subjected to western blotting with the primary anti-1C11 monoclonal antibody and anti-mouse second antibodies labeled with Alexa Fluor 488 dye (Molecular Probes); the banding pattern was analyzed using the Odyssey infrared imaging system (LI-COR, Biosciences).
RESULTS

Cross-linking of EpCai by Cu-OP-
We investigated the effect of Cu-OP oxidation on the cysteine thiol groups of EpCai. Cells producing EpCai were incubated with various concentrations of Cu-OP at 20°C for 15 min. The reaction was stopped by the addition of EDTA to trap free and complexed Cu , and of NEM to block the remaining free cysteine residues. Samples were separated by SDS-PAGE and EpCai was detected by immunoblotting with monoclonal antibody (mAb) 1C11 directed against the epitope tag of EpCai (Fig. 2) . Increasing concentrations of Cu-OP decreased the intensity of the band corresponding to the monomeric form of EpCai (apparent molecular mass of 18-kDa) and increased the intensity of the band corresponding to the dimeric form (36-kDa) ( Fig. 2A) . After treatment with β-me, the 36-kDa band disappeared, with all EpCai migrating in the 18-kDa band ( Fig. 2A) . These results strongly suggest that the 36-kDa band corresponded to a dimer of EpCai, stabilized by an intermolecular disulfide bond. This dimer will hereafter be referred to as [EpCai] 2. To confirm the existence of the dimer, another cross-linking reagent, formaldehyde (FA), was used. Cells producing EpCai were treated with 1% FA for 15 min, and the proteins were separated by SDS-PAGE. Both EpCai and [EpCai] 2 were detected in FA-treated samples, but only the band corresponding to the monomeric EpCai was visible in the absence of FA treatment, and in FA-treated samples that were subsequently heated to break any cross-links (Fig. 2B ). Although these results suggest that EpCai exists as a dimer in the membrane, the possibility that EpCai interacts with another protein that has a similar apparent molecular mass to form an heterodimer cannot be formally excluded. To demonstrate that the observed 36-kDa band indeed corresponds to an homodimer of EpCai, we used a larger variant of Cai, called VL1 (20) . In absence of Cu-OP, monomeric VL1 migrated on SDS-PAGE as a single band of 30 kDa apparent molecular mass. Following treatment with Cu-OP, a second band of 60-65 kDa apparent molecular mass was observed, undoubtedly a homodimer of VL1 because cross-linking between VL1 and a hypothetical protein of an apparent molecular mass of 18 kDa would not migrate to this position (Fig. 2C) . These results clearly indicate that Cai forms homodimers in the E. coli inner membrane. Interestingly, following treatment with 20 µM of Cu-OP, two other bands that migrated close to EpCai or [EpCai] 2 were detected ( Fig. 2A) . These bands may correspond to EpCai monomers and dimers that react with Cu-OP to form intramolecular disulfide bonds. Indeed, these bands disappeared in the presence of a reducing agent and only the band corresponding to the monomeric form of EpCai was observed. Preincubation of cells with NEM prior Cu-OP addition prevented intra and intermolecular disulfide bond formation ( Fig. 2A) . We used mutagenesis experiments to identify the cysteine residues involved in these intra and intermolecular disulfide bonds.
Cys107-Cys107 disulfide bond mediates
EpCai dimerization-EpCai possesses cysteine residues at positions 31, 74, 107 and 122. All these four cysteine residues are located in TMSs. Cys31 is located in TMS1, Cys74 in TMS2 and Cys107 and Cys122 in TMS3 (Fig.  1) . To identify the cysteine residue(s) involved in EpCai dimerization following incubation with Cu-OP, we constructed four mutated EpCai proteins, each with a different single cysteine replaced with serine. EpCai C31S , EpCai C107S and EpCai C122S were produced in similar amounts as the wild-type but EpCai C74S could not be detected by immunoblotting with the monoclonal antibody 1C11 (Fig. 3A) . Furthermore, EpCai C31S , EpCai C107S and EpCai C122S each conferred the ColA-insensitive phenotype to an E. coli strain transformed with the corresponding plasmids, whereas the same strain transformed with the EpCai C74S construct stayed ColA-sensitive (table 1) . We discovered that the Cys 74 to Ser transition led to a thermosensitive phenotype and therefore evaluated EpCai C74S production at various temperatures ( Fig. 3B ): EpCai C74S was detected at 25°C, 30°C, and 33°C but not at 37°C. Moreover, an E.coli strain transformed by the plasmid encoding EpCai C74S was insensitive to ColA at 30°C demonstrating that EpCai C74S is produced and functional at this temperature. To identify the residue involved in EpCai dimerization, cells producing the various mutated EpCai were incubated with each of a series of concentrations of Cu-OP. Doses of 20 to 50 µM Cu-OP effectively catalyzed the dimer formation for EpCai wt, EpCai C31S , EpCai C74S and EpCai C122S whereas 100 µM Cu-OP was required for EpCai C107S dimerization (Figs. 3C & 2A). These results suggest that Cys107 is involved in EpCai dimerization at low Cu-OP concentrations, and that if it is replaced by a serine residue, EpCai can dimerize at high Cu-OP concentration through another cysteine residue. Each of the EpCai mutants was incubated with Cu-OP and subjected to western blotting. A band corresponding to an oxidized monomeric form of EpCai was detected for EpCai C31S , EpCai C107S and EpCai C122S but not for EpCai C74S . This suggests that Cys74 is involved in intramolecular disulfide bonds with either Cys31, Cys107 or Cys122.
[EpCai] 2 dimerizes through its TMS3-To identify the cysteine residue involved in the dimerization of EpCai carrying the C107 to Ser mutation, we constructed the following double serine substitutions: Ser31/Ser107; Ser74/Ser107; and Ser107/Ser122, and tested them for dimerization upon Cu-OP incubation. Dimer formation was observed for all the double-mutants except S107/S122 (Fig. 4A) . Therefore, EpCai preferentially forms dimers through Cys107 (Fig. 3C ), but can also dimerize through Cys122 if Cys107 is absent (Fig. 4A ). EpCai C107S/C122S is unable to form dimers following treatment with Cu-OP (Fig.  4A ), so we tested whether this double EpCai mutant exists as a monomer or a dimer in the inner membrane. We found that dimers of EpCai C107S/C122S were be observed following FA treatment (Fig. 4B ), demonstrating that even in absence of C107 and C122, EpCai exists as a dimer in the inner membrane.
Systematic cysteine scanning mutagenesis of TMS3. To determine which face of the TMS3 helix is involved in EpCai dimerization, we used the S107/S122 double mutant and substituted several other residues of TMS3 with cysteine. Sixteen unique cysteine mutations covering TMS3 residues 106 to 123 were constructed (Fig. 5A) . Following oxidation, most of the cysteine variants were observed as dimers, which reverted to monomers after treatment with βme. At low concentrations of Cu-OP (20 and 50 µM), all constructs with substitutions at positions 106-109 were efficiently cross-linked, suggesting that this part of the helix is relatively mobile, consistent with its location at the helix end, close to the cytoplasm. Note that C107 is in this region. For the cysteine substitutions at positions 110 to 123, only the mutants with cysteine residues on one face of the helix were able to cross-link, as depicted on the helical wheel projection in figure 5B showing the positions of the residues involved in EpCai dimerization; This face of the TMS3 helix is on the side opposite C107.
Intramolecular disulfide bonds connect TMS1 to TMS2 or TMS2 to TMS3-We show above that Cys74 is involved in intramolecular disulfide bond formation ( Fig. 3C ) with Cys31, Cys122 or Cys107. However single C31S, C107S and C122S substitutions did not abolish intramolecular disulfide bonds, suggesting that Cys74 is in close contact with at least two other cysteines.
The C31S/C107S and C107S/C122S EpCai mutants, but not the C31S/C122S mutant, were able to form intramolecular bonds (Fig. 4A) . Therefore, formation of intramolecular disulfide bonds required the presence of Cys74 and Cys31 or Cys74 and Cys122. In agreement with this result, these three cysteine residues are located on the periplasmic side of TMSs whereas Cys107 is located on the cytoplasmic side (Fig.  1) .
The hydrophobic helical hairpin of pfColA prevents cross-linking of EpCai by Cu-OP-
Our results indicate that EpCai dimerizes through the TMS3 in the inner membrane and that TMS2 is in close contact with TMS1 and TMS3. To determine the effect of the interaction between the pore-forming domain of ColA and EpCai, we co-produced the two proteins in the inner membrane. The pore-forming domain of ColA (pfColA) fused to a signal peptide (sp-pfColA) inserts into the inner membrane of E. coli and forms a functional channel (24) . However, an E. coli strain harboring a plasmid encoding EpCai is immune to sp-pfColA and therefore EpCai and sp-pfColA can be produced in the same cells (17) . The production of EpCai was induced first through the addition of IPTG (100 µM). One hour later, production of sp-pfColA was induced by the addition of arabinose (0.5 mg/ml) for 30 min. In these conditions, sppfColA is produced in excess with respect to the EpCai and is lethal for the producing bacteria (24) . Last, Cu-OP was added or not to the culture, which were incubated for 15 min and then harvested. The two proteins were detected by immunoblotting with the monoclonal antibody 1C11 and with a polyclonal antibody directed against pfColA (Fig. 6A ). In the absence of sp-pfColA, EpCai was converted into [EpCai] 2 upon Cu-OP treatment, as described above. Conversely, the production of sp-pfColA led to the absence of [EpCai] 2 , and only the reduced monomeric form of EpCai was detected (Fig. 6A) . This indicates that the interaction between pfColA and EpCai prevents both [EpCai] 2 formation and intramolecular disulfide bond formation by Cu-OP. To confirm these findings, we constructed three new single cysteine mutants: L109C, V113C, and Y119C. These three mutated EpCai efficiently protected the producing cells against ColA at 30°C. As for the C74S substitution, the Y119C substitution led to a thermosensitive phenotype (data not shown). These three single cysteine mutants dimerized following incubation with Cu-OP either through the native C107 or the introduced cysteine (Fig. 6B) . Furthermore, trimeric forms of EpCai were observed suggesting that the native and the introduced cysteines can both simultaneously form disulfide bonds. In the presence of pfColA, none of the three mutated EpCai proteins dimerized upon Cu-OP incubation. This indicates that the presence of pfColA prevents dimerization of EpCai irrespective of the position of cysteines in TMS3. Analogous results were obtained with the inactive EpCai triple mutants C107S/L109C/C122S, C107S/V113C/C122S and C107S/Y119C/C122S, which contain only one cysteine in TMS3. To corroborate these results, we performed cross-linking experiments in presence of another crosslinker, FA that can react with primary amino groups: in the presence of sp-pfColA, EpCai wt was only detected as a monomer (Fig. 6C) . We tested whether sp-pfColA in its closed state similarly prevented EpCai cross-linking by Cu-OP. We used sp-pfColA B3 which carries two substitutions (A492E/F493P) in the loop region connecting helices 5 and 6 of pfColA. This double substitution abolishes the channel activity of pfColA but does not prevent membrane insertion (25) . We produced EpCai in the presence and absence of sp-pfColA B3 and performed the cross-linking assay with Cu-OP (Fig. 6A) . In the closed state, pfColA prevented Cu-OP catalyzed cross-linking of EpCai wt (Fig. 6A) and mutated EpCai proteins (data not shown). Therefore, channel activity is not required and the presence of sp-pfColA in the membrane is sufficient to abolish EpCai cross-linking.
EpCai incubated with Cu-OP is inactive-
We next tested whether covalent Cai dimers protected the cell against ColA. Cells producing Cai were totally immune to ColA, whereas ColA efficiently killed sensitive, Caifree cells (Fig. 7A) . Surprisingly, sensitive cells incubated with Cu-OP became insensitive to ColA but remained sensitive to other poreforming colicins, including ColE1 and ColB, and to the nuclease colicins ColE2 (Fig. 7A) . We suspected that at least one of the proteins involved in the ColA translocation through the E. coli envelope was affected by Cu-OP. To test this we added hybrid colicins AAB and BBA (26) to sensitive cells incubated in the presence or absence of Cu-OP. ColAAB consists of the first two domains of ColA fused to the pore-forming domain of ColB, and ColBBA consists of the first two domains of ColB fused to the pore-forming domain of ColA. As expected, the two hybrid colicins were fully active against sensitive cells, whereas only ColBBA was active against sensitive cells incubated with Cu-OP (Fig. 7B) . This confirms that ColA binding or translocation through the E. coli envelope is affected by Cu-OP, but that pore-forming activity is not. We then tested ColBBA activity on cells producing Cai incubated with or without Cu-OP. In the absence of Cu-OP, Cai effectively protected the cells against added ColBBA (12) . Conversely, the protection conferred by Cai was completely abolished by by guest on August 17, 2017 http://www.jbc.org/ Downloaded from incubation with Cu-OP (Fig. 7C ). This clearly demonstrates that the oxidized Cai locked by disulfide bonds is unable to prevent ColA pore-formation.
To determine which disulfide bonds inactivate Cai, we tested ColBBA activity on cells producing either EpCai C107S/C122C or EpCai C74S . In the presence of Cu-OP, EpCai C107S/C122C is unable to form intermolecular disulfide bonds and EpCai C74S does not form intramolecular disulfide bonds. These two mutated EpCai were inactive when Cu-OP was added (Fig. 7D) , suggesting that the intramolecular and the intermolecular disulfide bonds are both independently able to inactivate the immunity protein.
Finally, to demonstrate that the EpCai inactivity following incubation with Cu-OP results from disulfide bond formation and not from any secondary effects of metal ions such as Cu 2+ , we tested ColBBA activity on cells producing and not producing EpCai in the presence of Cu-OP and in the presence of the reducing agent DTT (Fig. 7E) . In the presence of DTT, EpCai effectively protected the cells against the lethal action of ColBBA, and reversed the effect of Cu-OP.
DISCUSSION
The topological model of Cai, constructed from biochemical and genetic analyses (10, 11) , indicates the presence of four transmembrane segments. However, little was known about either the three-dimensional arrangement of the TMSs within the inner membrane or the oligomeric state of Cai. The Cai sequence does not contain any canonical motif likely to mediate the non-covalent association of the TMSs: in particular, there is no leucine heptad motif and no GXXXG motif, known to mediate association of TMSs (27, 28) .
To investigate the helix packing of Cai, we used Cu-OP, a zero-length cross-linker of Cys residues. In the presence of Cu-OP, EpCai migrated as a dimer in SDS-PAGE. We studied the physiological relevance of this dimerization.
Indeed, the observed dimerization may have been artifactual, resulting from simple aggregation of EpCai and/or random collisions. In a previous study on the biosynthesis and insertion of Cai, Géli et al., 1989, found that non-inserted Cai protein did not aggregate but was rapidly degraded (10); consequently, they indicate that the amount of Cai detected in the membrane by immunoblot analysis after SDS-PAGE reflects insertion of Cai into the membrane. Here, we verified that after induction of the genetic construct, EpCai was recovered in the membrane fraction and was only solubilized in the presence of detergent suggesting that the protein was correctly inserted into the inner membrane and not aggregated (data not shown). Ji and Middaugh (1980) demonstrated that the formation of random collisional crosslinking of membrane proteins is a rare event occurring only under extreme conditions of high protein concentration and long times of incubation (29) . Even after inducting overexpression of the gene, EpCai has been reported to be only minor protein of the inner membrane (20) . Furthermore, we used short times of incubation (usually 15 min) with Cu-OP or FA to assure that cross-linking reflected specific interactions rather than random proximity. Three further observations confirm that EpCai dimers occur naturally: EpCai appears to dimerize along a specific surface (TMS3) rather than randomly; secondly, point mutation, specifically abolished dimer formation; and finally EpCai dimer formation was completely abolished by the presence of its target, the ColA C-terminal domain.
In the presence of Cu-OP, we detected a shift in the electrophoretic mobility of EpCai ( Fig. 2A) . We associated this mobility shift to the formation of an intramolecular disulfide bond. Such mobility shifts have been previously used to analyze cross-linking of the Tar chemotactic receptor (30), and subunit a of Escherichia coli ATP synthase (31). In general, cross-linking between helices results in a more compact structure in SDS leading to a faster electrophoretic migration through the polyacrylamide gel. However, the presence of a disulfide bond can also have an opposite effect and lead to lower electrophoretic mobility, as for example the cardiac Na + -Ca + exchanger proteins (32). In our case, disulfide bond formation reduced the mobility of EpCai in SDS-PAGE (Figs. 2A, 3 & 4) . This shift in the mobility can be attributed to formation of an intramolecular disulfide bond between TMSs of EpCai for the following reasons: (i) in the absence of Cu-OP, this shift was never observed (Figs. 2A & B) , (ii) the sequential treatment with Cu-OP, NEM, and then β-me which reduces and breaks disulfide bonds, abolished the shift in mobility (Fig. 2A) , and (iii) we did not observe a shift after Cu-OP treatment either with the mutants EpCai C74S and EpCai C31S/C122S or when WT EpCai was coproduced with sp-pfColA (Figs. 3C, 4A &  6A) .
To identify the cysteine residues involved in intra-and intermolecular disulfide bond formation, we used a reverse cysteine scanning approach. A mutated form of EpCai lacking all of the four natural cysteine residues was constructed. However, this EpCai quadruple mutant was unstable, even at low temperature, and could not be visualized by western blotting. Only in those constructs with single serine mutations or the double serine mutation C31S/C107S was EpCai activity not significantly affected. All other mutations (double or triple) affected EpCai activity to various degrees (Table 1 ). However, we were able to visualize and discriminate all the different forms of the mutated proteins by western blotting (monomer versus dimer, with or without intramolecular disulfide bonds), and therefore obtain information about helix packing in the membrane. We clearly demonstrate that EpCai forms homodimers through its TMS3, and that in one monomer TMS2 is in close contact with TMS1 and TMS3. The natural cysteine 107 and the region of the TMS3 helix involved in dimer formation are on opposite side of TMS3 (Fig. 5B) . When the residues at positions 106 to 109 are substituted with cysteines they are able to cross-link like the natural cysteine 107, suggesting that this region is flexible. Such flexibility is consistent with its location at the N-terminal end of TMS3, and could explain why C107 is able to come into close proximity with the same residue of a neighboring monomer. Thus, EpCai appears to form homodimers through one face of the TMS3 helix, and that the observed cross-linking through the native cysteine 107 is possible because of the high flexibility of the 106-109 region. The high mobility of the 106-109 region and C107 in particular may explain why EpCai is able to form trimers when cysteines are introduced in positions 109, 113 and 119 (Fig. 6B) . Two observations are quite surprising: the failure of the A126C construct to cross-link and the efficient cross-linking of the F121C construct (Fig. 5B) . The A126C mutant may be unable to cross-link due to the tight packing of residues at the interface of the helix dimer. A126C may be disruptive as a result of steric hindrance to helix packing. F121 is at the end of the helix, close to the periplasm and therefore may be in a relatively mobile region. These various findings allow us to propose a preliminary model of the arrangement of the helices in the membrane (Fig. 8) .
Interestingly, the presence of pfColA modifies Cai helix packing. When pfColA is co-produced and targeted to the E. coli inner membrane, EpCai does not form any disulfide bonds, indicating that pfColA modifies both the dimer interface of EpCai and the respective orientations of the TMSs within the monomers. Disulfide bonding is also inhibited by an inactive from of pfColA, which inserts into the membrane by its hydrophobic helical hairpin, but is unable to form a channel. The hydrophobic helical hairpin of pfColA thus alters the relative distances between residues 31 and 74, and residues 74 and 122 in within the protein molecule and also between residues 107, 109, 113, 119 of adjacent protein molecules. Interaction between EpCai and its target pfColA results in major modifications of the helix packing in EpCai, and in particular an increase of the distance between the two adjacent TMSs3. This interaction also prevented C107 from forming a disulfide bond with the same residue of a neighboring monomer, indicating decreased flexibility of the C106-C109 region. TMS3 has been identified as a key region for helix-helix interaction between immunity proteins and their cognate colicins (33-35). Possibly, in the absence of pfColA, the arrangement of the TMSs of EpCai are mobile as suggested by the intramolecular disulfide bonds formed in oxidative conditions being at any of various different positions. Espesset et al. (1994) suggested that a certain degree of mobility between the helices of EpCai might be important for the interaction between these helices and the hydrophobic helical hairpin of the pore-forming domain and the subsequent inactivation of the colicin. In agreement with this notion, an intermolecular disulfide bond or an intramolecular disulfide bond introduced into EpCai that reduced inter-helix mobility also inactivated the protein (Fig. 7) . It is also clear that the conformation of EpCai in the presence of pfColA is different from that in its absence: the presence of pfColA leads to the absence of both intramolecular and intermolecular disulfide bonds (Fig. 6A) .
In summary, investigating cross-linking involving introduced or native cysteine residues in Cai allowed us to show that Cai is a dimer in the membrane. The positions of cysteine involved in intra-or intermolecular disulfide bonds allow us to propose a model of the dimer showing both the arrangement of the TMSs in the monomers, and that TMS3 is involved in dimerization. Most importantly we found that pfColA interacts with the Cai dimer, and that this interaction modifies both Cai dimer interaction, and the arrangement of the helices inside the two monomers. Although we do not show conclusively that pfColA dissociates the EpCai dimer, preliminary results reported here are in favor of this hypothesis (Fig. 6) 
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